Organogenesis Holdings (ORGO) Stock Statistics & Valuation Metrics

Organogenesis Holdings has a market cap or net worth of $342.27M. The enterprise value is $321.04M.

Organogenesis Holdings has 128,674,550 shares outstanding. The number of shares has decreased by -2.65% in one year.

Organogenesis Holdings’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 8.52%.

The current PE Ratio of Organogenesis Holdings is ―. Organogenesis Holdings’s PEG ratio is -0.00753.

In the last 12 months, Organogenesis Holdings had revenue of 563.03M and earned 37.03M in profits. Earnings per share was 0.16.

In the last 12 months, operating cash flow was 30.75M and capital expenditures -13.67M, giving a free cash flow of 17.08M billion.

Organogenesis Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Organogenesis Holdings upcoming earnings date is Aug 6, 2026, After Close (Confirmed).

Organogenesis Holdings as a current ratio of 3.62, with Debt / Equity ratio of 18.58%

In the past 12 months, Organogenesis Holdings has paid 9.94M in taxes.

Organogenesis Holdings EV to EBITDA ratio is 8.40, with an EV/FCF ratio of -28.44.

Organogenesis Holdings has $92.10M in cash and marketable securities with $70.86M in debt, giving a net cash position of $21.24M billion.

Gross margin is 70.41%, with operating margin of 9.92%, and net profit margin of 6.58%.

The average price target for Organogenesis Holdings is ―, which is 11.43% higher than the current price. The consensus rating is Hold